Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vilma Valceckiene"'
Autor:
Regina Pileckyte, Vilma Valceckiene, Mindaugas Stoskus, Reda Matuzeviciene, Jurgita Sejoniene, Tadas Zvirblis, Laimonas Griskevicius
Publikováno v:
Medicina, Vol 55, Iss 11, p 719 (2019)
Background and Objectives: BTK and BCL2 inhibitors have changed the treatment paradigms of high-risk and elderly patients with chronic lymphocytic leukemia (CLL), but their long-term efficacy and toxicity are still unknown and the costs are considera
Externí odkaz:
https://doaj.org/article/44968006ae5f456f8592a8f0c7e74c46
Autor:
Mindaugas Stoškus, Jurgita Sejoniene, Tadas Zvirblis, Vilma Valceckiene, Reda Matuzeviciene, Laimonas Griskevicius, Regina Pileckyte
Publikováno v:
Medicina
Volume 55
Issue 11
Medicina; Volume 55; Issue 11; Pages: 719
Medicina, Basel : MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Kaunas; Basel : LSMU, MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Vol 55, Iss 11, p 719 (2019)
Volume 55
Issue 11
Medicina; Volume 55; Issue 11; Pages: 719
Medicina, Basel : MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Kaunas; Basel : LSMU, MDPI, 2019, vol. 55, no. 11, art. no. 719, p. [1-10]
Medicina, Vol 55, Iss 11, p 719 (2019)
Background and Objectives: BTK and BCL2 inhibitors have changed the treatment paradigms of high-risk and elderly patients with chronic lymphocytic leukemia (CLL), but their long-term efficacy and toxicity are still unknown and the costs are considera
Publikováno v:
British Journal of Haematology. 151:232-238
The clinical heterogeneity of B-cell chronic lymphocytic leukaemia (B-CLL) makes it necessary to identify potent prognostic indicators to predict individual clinical course and select risk-adapted therapy. In recent years, numerous gene expression mo
Autor:
Gintaras Kaubrys, Loreta Bagdonaite, Mindaugas Stoškus, Laimonas Griskevicius, Natasa Giedraitiene, Vilma Valceckiene, Rasa Kizlaitiene
Publikováno v:
Medical science monitor, Warsaw : Medical Science International, 2015, vol. 21, p. 1512-1519
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background: Neutralizing antibodies (NAb) to interferon-beta (IFN-b) are associated with reduced bioactivity and efficacy of IFN-b in multiple sclerosis (MS). The myxovirus resistance protein A (MxA) gene expression is one of the most appropriate mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c099b8068ae22884c2e04be34a6c883f
https://repository.vu.lt/VU:ELABAPDB8811102&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB8811102&prefLang=en_US
Autor:
Mindaugas Stoškus, Jurgita Sejoniene, Laimonas Griskevicius, Vilma Valceckiene, Regina Pileckyte, Mindaugas Jurgutis, Egle Gineikiene, Tadas Zvirblis, Andrius Degulys
Publikováno v:
Leukemialymphoma. 52(6)
This study evaluated the efficacy and safety of dose-dense high-dose methylprednisolone (HDMP) plus rituximab (Rtx) in patients with high-risk CLL. Twenty-nine patients with relapsed or progressive CLL with adverse cytogenetics (17p deletion, TP53 mu
Autor:
Regina Pileckyte, Mindaugas Stoškus, Vilma Valceckiene, Beatrice Valatkaite, Egle Gineikiene, Laimonas Griskevicius
Publikováno v:
Blood cells, moleculesdiseases. 46(4)
Insulin-like growth factor 2 mRNA-binding proteins IGF2BP1, IGF2BP2, and IGF2BP3 have been shown to have diagnostic and prognostic utility in a number of epithelial and soft tissue tumors. Still, little is known about the expression of these molecule
Publikováno v:
British journal of haematology. 151(3)
The clinical heterogeneity of B-cell chronic lymphocytic leukaemia (B-CLL) makes it necessary to identify potent prognostic indicators to predict individual clinical course and select risk-adapted therapy. In recent years, numerous gene expression mo
Autor:
Kristina Andrekute, A. Jakubauskas, Arvydas Kanopka, Laimonas Griskevicius, Vilma Valceckiene, Dmitrij Seinin
Publikováno v:
Experimental and molecular pathology. 90(2)
The most common recurrent translocation in clear cell sarcoma t(12;22)(q13;q12) results in an EWSR1/ATF1 chimeric gene. We present a molecular analysis of tumor overgrowing right proximal tibia with bone destruction metastatic to two groin lymph node
Publikováno v:
Leukemia & Lymphoma. Sep2015 Supplement, Vol. 56, p1-166. 166p.
Autor:
Pileckyte, Regina1 (AUTHOR) regina.pileckyte@santa.lt, Jurgutis, Mindaugas2 (AUTHOR), Valceckiene, Vilma3 (AUTHOR), Stoskus, Mindaugas3 (AUTHOR), Gineikiene, Egle3 (AUTHOR), Sejoniene, Jurgita4 (AUTHOR), Degulys, Andrius1 (AUTHOR), Zvirblis, Tadas1 (AUTHOR), Griskevicius, Laimonas1,5 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Jun2011, Vol. 52 Issue 6, p1055-1065. 11p. 5 Charts, 3 Graphs.